Statins, Diuretics, DAPT: Drug-Nutrient Depletion | Healos™
Statins, Diuretics, and DAPT: The Drug-Nutrient Debt (For Clinicians)
# Clinicians #Drug-Nutrient Interactions #Statins #Diuretics #DAPT #PPI #CoQ10 #Magnesium #Vitamin B12
Every drug on a standard post-cardiac discharge list earns its place. Statins, antiplatelet therapy, beta-blockers, ACE inhibitors and diuretics each have a strong evidence base for secondary prevention, and nothing in this article argues for changing them.
What they also have is a nutritional side ledger. Month after month, predictable effects on coenzyme Q10, magnesium, potassium, vitamin B12 and iron accumulate quietly, and they surface at 6, 12 or 18 months as fatigue, cramps, palpitations, low mood or declining exercise tolerance that doesn't quite fit the clinical picture.
The short answer for busy clinicians: standard post-cardiac medications have predictable nutritional side effects. Statins lower coenzyme Q10, loop and thiazide diuretics increase magnesium and potassium loss, long-term proton pump inhibitors used with DAPT can lower magnesium and vitamin B12, metformin lowers B12, and low-dose aspirin can contribute to iron deficiency. ACE inhibitors and aldosterone antagonists do the opposite with potassium.
写给忙碌临床医生的简短答案：
标准心脏术后出院药单上的每一种药都有充分理由：他汀、抗血小板、β 阻滞剂、ACEI 和利尿剂在二级预防中都有坚实证据，本文不主张改变它们。
但它们还有一本「营养副账」：对辅酶 Q10、镁、钾、B12 和铁的可预测影响逐月累积，在 6、12 或 18 个月时以疲劳、抽筋、心悸、情绪低落或运动耐量下降的形式出现，而且与临床表现对不上。
他汀降低辅酶 Q10；利尿剂增加镁钾流失；与 DAPT 同用的长期 PPI 可降低镁和 B12；二甲双胍降低 B12；低剂量阿司匹林可能导致缺铁；ACEI 和醛固酮拮抗剂则会使钾升高。
Statins and coenzyme Q10: real depletion, contested remedy
Statins inhibit HMG-CoA reductase, the same mevalonate pathway step that leads to coenzyme Q10 synthesis. The effect on circulating levels is well documented: high-dose atorvastatin lowered blood CoQ10 by about half within 30 days (Rundek et al., Archives of Neurology, 2004). Whether muscle CoQ10 falls to a clinically meaningful degree is less clear.
The treatment question is genuinely contested. A 2018 meta-analysis found that CoQ10 supplementation reduced statin-associated muscle symptoms (Qu et al., Journal of the American Heart Association, 2018), while an earlier one did not (Banach et al., Mayo Clinic Proceedings, 2015). The pragmatic position: in a patient with muscle symptoms who is at risk of discontinuing a statin, CoQ10 is a low-risk option worth discussing, provided it keeps the patient on the statin rather than replacing it. The patient-facing version of this discussion is in statins deplete CoQ10.
他汀与辅酶 Q10：真实的消耗，有争议的补救：
他汀抑制 HMG-CoA 还原酶，这正是通向辅酶 Q10 合成的甲羟戊酸通路同一步骤。对血液水平的影响有充分记录：高剂量阿托伐他汀 30 天内使血液 CoQ10 降低约一半；肌肉组织是否降到有临床意义的程度则不太清楚。
补充是否有效确有争议：2018 年荟萃分析发现 CoQ10 可减少他汀相关肌肉症状（JAHA），而 2015 年的一项则未发现（Mayo Clin Proc）。务实立场：对于有肌肉症状、可能停用他汀的患者，CoQ10 是值得讨论的低风险选项，前提是让患者继续服用他汀，而非取而代之。
Diuretics: magnesium, potassium and a calcium twist
Loop and thiazide diuretics increase urinary losses of magnesium and potassium. Low magnesium is associated with arrhythmias and makes hypokalaemia harder to correct, because potassium repletion is less effective while magnesium remains low. In patients on long-term diuretics, particularly with heart failure or atrial fibrillation, periodic magnesium measurement alongside potassium is worthwhile, recognising that serum magnesium underestimates total body stores.
Thiazides add a twist: they reduce urinary calcium excretion. In patients also taking calcium and vitamin D supplements, which is common in older women, that combination occasionally produces hypercalcaemia. It is worth knowing what the patient is taking over the counter.
利尿剂：镁、钾与钙的反转： 袢利尿剂和噻嗪类增加尿中镁钾流失。低镁与心律失常相关，并使低钾更难纠正，因为镁偏低时补钾效果较差。长期使用利尿剂者（尤其合并心衰或房颤）宜在测钾的同时定期测镁，但要注意血清镁会低估体内总储量。
噻嗪类还有一个反转：它减少尿钙排出，对同时补钙和维生素 D 的患者（老年女性常见）偶尔会导致高钙血症，值得了解患者在服用哪些非处方产品。
DAPT's hidden companions: PPIs, iron and bleeding
Antiplatelet therapy itself doesn't deplete many nutrients, but it brings two companions.
Proton pump inhibitors. PPIs are often co-prescribed for gastrointestinal protection during DAPT. In 2011, the US FDA warned that long-term PPI use, generally over a year, can cause hypomagnesaemia. Two or more years of PPI use has also been associated with a 65% higher odds of vitamin B12 deficiency (Lam et al., JAMA, 2013). The PPI is often continued long after DAPT has been stepped down; each review is an opportunity to ask whether it's still needed. (Where clopidogrel is used, pantoprazole avoids the CYP2C19 interaction associated with omeprazole and esomeprazole.)
Iron. Low-dose aspirin causes small amounts of occult gastrointestinal blood loss. In the ASPREE trial of older adults, aspirin increased incident anaemia by about 20% and was associated with lower ferritin (McQuilten et al., Annals of Internal Medicine, 2023). In patients on DAPT or aspirin plus an anticoagulant, unexplained fatigue warrants a ferritin as well as a haemoglobin.
Bleeding-additive supplements. Patients on antiplatelets often add high-dose fish oil, vitamin E, ginkgo, turmeric or garlic extracts without mentioning it. Individually the effects are usually modest, but they add to bleeding risk and are rarely recorded.
DAPT 的隐藏同伴：PPI、铁和出血： 抗血小板药本身耗尽的营养素不多，但它带来两个同伴。
质子泵抑制剂：DAPT 期间常联用 PPI 保护胃肠道。2011 年美国 FDA 警告长期（通常超过一年）使用 PPI 可致低镁血症；使用两年以上与维生素 B12 缺乏几率高 65% 相关（JAMA 2013）。DAPT 降阶后 PPI 常被继续使用，每次复查都是评估是否仍需要的机会（使用氯吡格雷时，泮托拉唑可避免奥美拉唑/埃索美拉唑的 CYP2C19 相互作用）。
铁：低剂量阿司匹林会造成少量隐性消化道失血，ASPREE 试验中阿司匹林使老年人新发贫血增加约 20%，并与铁蛋白降低相关（Ann Intern Med 2023）；服用 DAPT 或阿司匹林加抗凝药者出现不明原因疲劳时，应同时查铁蛋白和血红蛋白。
叠加出血风险的补充剂：服用抗血小板药的患者常自行加用高剂量鱼油、维生素 E、银杏、姜黄或大蒜提取物而不告知医生，单独影响通常不大，但会叠加出血风险且很少被记录。
Metformin, beta-blockers and the potassium surplus
Metformin. Many post-cardiac patients have type 2 diabetes. Long-term metformin use was associated with vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study (Aroda et al., Journal of Clinical Endocrinology & Metabolism, 2016). Combined with a PPI, the risk compounds, and B12 deficiency can present as neuropathy, cognitive complaints or fatigue that is easily attributed to something else.
Beta-blockers and sleep. Some beta-blockers reduce nocturnal melatonin secretion (Stoschitzky et al., European Journal of Clinical Pharmacology, 1999). It is one plausible contributor when patients report new insomnia after starting therapy, and worth considering before adding a sedative.
The opposite problem: potassium surplus. ACE inhibitors, ARBs and mineralocorticoid receptor antagonists raise potassium. Patients who add potassium supplements or switch to potassium-based salt substitutes, often on well-meaning advice to reduce sodium, can develop hyperkalaemia, especially with reduced kidney function. The medication list and the grocery list need to be read together.
二甲双胍、β 阻滞剂与「钾盈余」：
二甲双胍：很多心脏术后患者合并 2 型糖尿病，DPPOS 研究中长期服用二甲双胍与 B12 缺乏相关；与 PPI 同用风险叠加，B12 缺乏可表现为周围神经病、认知问题或疲劳，容易被归咎于其他原因。
β 阻滞剂与睡眠：部分 β 阻滞剂会降低夜间褪黑素分泌，患者开始治疗后出现新发失眠时，这是一个合理的因素，加用镇静药前值得考虑。
相反的问题——钾盈余：ACEI、ARB 和盐皮质激素受体拮抗剂会升高血钾，患者若出于减钠的好意加用钾补充剂或改用含钾代盐，可能出现高钾血症，肾功能减退者尤甚。用药清单和购物清单需要一起看。
A practical screening rhythm
None of this requires a new clinic. A simple rhythm covers most of it:
At each medication review, record over-the-counter supplements and salt substitutes as carefully as prescriptions.
Check magnesium with potassium in patients on long-term diuretics or PPIs.
Check B12 in patients on metformin, long-term PPIs, or both, and in anyone with new neuropathy or cognitive complaints.
Add ferritin when patients on antiplatelet therapy report unexplained fatigue.
Ask about muscle symptoms before they become a reason to stop a statin.
Reassess whether a PPI is still indicated once DAPT is stepped down.
Healos supports this rhythm from the patient side. Every programme starts with the medication list, flags predictable drug-nutrient effects and possible supplement interactions in the H-Index pre-visit summary, and routes anything that needs clinical judgement back to the prescriber. Healos™ products are Health Canada NPN-licensed and positioned as complementary support; prescribing decisions stay with you.
实用的筛查节奏： 这些都不需要新开一个门诊，一个简单节奏就能覆盖大部分：
每次药物复查时，像记录处方一样认真记录非处方补充剂和代盐；
长期使用利尿剂或 PPI 者，测钾时一并测镁；
服用二甲双胍、长期 PPI 或两者兼有者，以及新发神经病变或认知问题者，检查 B12；
服用抗血小板药的患者出现不明原因疲劳时加查铁蛋白；
在肌肉症状成为停用他汀的理由之前主动询问；
DAPT 降阶后重新评估 PPI 是否仍有指征。
Healos™ 从患者一侧支持这一节奏：每个方案都从用药清单开始，在 H-Index™ 就诊前摘要中标记可预测的药物-营养影响和可能的补充剂相互作用，并把任何需要临床判断的事项转回处方医生。Healos™ 产品获 Health Canada NPN 许可，定位为辅助支持，处方决策始终由您做出。
The bottom line
The post-cardiac prescription list is correct. It also runs up a predictable nutritional debt that rarely appears on anyone's checklist until it shows up as a symptom. Naming that debt early, and screening for it on a simple rhythm, keeps patients on the medications that protect them.
结论： 心脏术后处方是正确的，但它也会累积一笔可预测的营养债，在以症状出现之前很少出现在任何人的清单上。及早点明这笔债，并按简单节奏筛查，能让患者继续服用保护他们的药物。
Frequently asked questions
Which cardiac medications deplete nutrients? Statins lower coenzyme Q10; loop and thiazide diuretics increase magnesium and potassium loss; long-term proton pump inhibitors can lower magnesium and vitamin B12; metformin lowers B12; and low-dose aspirin can contribute to iron deficiency through occult blood loss.
Should patients on statins take CoQ10? Evidence is mixed. Statins lower circulating CoQ10, and one meta-analysis found supplementation reduced statin-associated muscle symptoms while another did not. For patients at risk of stopping a statin because of muscle symptoms, CoQ10 is a low-risk option to discuss, as long as the statin continues.
Do diuretics cause low magnesium? Yes. Loop and thiazide diuretics increase urinary magnesium and potassium losses. Low magnesium is associated with arrhythmias and makes low potassium harder to correct, so periodic monitoring is reasonable in long-term users.
Does long-term PPI use cause vitamin B12 deficiency? It can. Two or more years of proton pump inhibitor use was associated with 65% higher odds of B12 deficiency in a large JAMA study, and long-term use can also cause low magnesium. Reassessing the need for a PPI after DAPT is stepped down is worthwhile.
Can low-dose aspirin cause iron deficiency? It can contribute. In the ASPREE trial, low-dose aspirin increased incident anaemia by about 20% in older adults and was associated with lower ferritin, likely through small amounts of gastrointestinal blood loss.
常见问题：
哪些心脏药物会耗尽营养素？他汀降 CoQ10；利尿剂增加镁钾流失；长期 PPI 可降镁和 B12；二甲双胍降 B12；低剂量阿司匹林可因隐性失血导致缺铁。
服用他汀的患者要补 CoQ10 吗？证据不一，对因肌肉症状可能停用他汀者，是值得讨论的低风险选项，前提是继续服用他汀。
利尿剂会导致低镁吗？会，并使低钾更难纠正，长期使用者宜定期监测。
长期 PPI 会导致 B12 缺乏吗？可能，两年以上使用与 B12 缺乏几率高 65% 相关，也可致低镁，DAPT 降阶后应重新评估。
低剂量阿司匹林会导致缺铁吗？可能有影响，ASPREE 中阿司匹林使老年人新发贫血增加约 20%。
References
Rundek T, et al. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Archives of Neurology. 2004;61(6):889–892.
Qu H, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Journal of the American Heart Association. 2018;7(19):e009835.
Banach M, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clinic Proceedings. 2015;90(1):24–34.
US Food and Drug Administration. Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). 2011.
Lam JR, et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435–2442.
Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism. 2016;101(4):1754–1761.
McQuilten ZK, et al. Effect of low-dose aspirin versus placebo on incidence of anemia in the elderly: a secondary analysis of the ASPREE trial. Annals of Internal Medicine. 2023;176(7):913–921.
Stoschitzky K, et al. Influence of beta-blockers on melatonin release. European Journal of Clinical Pharmacology. 1999;55(2):111–115.
Custom HTML/CSS/JavaScript
